Biomea Fusion Company
Biomea Fusion is a precision oncology company developing novel small molecules that target aggressive forms of cancer.
Total Funding:
56000000.0
Headquarters:
Redwood City, California, United States
Funding Status:
IPO
Employee Number:
11-50
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series A
Technology:
Biotechnology, Life Science, Therapeutics
Last Funding Date:
2021-01-06
Investors Number:
8.0
Founded Date:
2017-01-01
Industry:
Early Drug Development